Roche

Roche Q1 Sales Flat as Illumina Bid Battle Rages

Fake Avastin Reached US via Britain

U.S. Medicine Spending Rose to $320 Billion Last Year

Roche Steps Up Pressure in Illumina Bid Battle

Chasing Cheaper Cancer Drugs

Columbia University Sues Illumina Over DNA Patents

Roche Extends Illumina Bid Again

EU Agency Issues Guideline on Biosimilar MS Drugs

Lonza Sees Growth on Pharma Outsourcing

Merck Inks New Non-Exclusive Agreement With Roche

Roche to Acquire 100% Of Privately-held mtm Laboratories

Roche to Provide Tests for Merck Cancer Drugs

Topics • Technology

The World Of Biosimilars

Roche Seen Kicking off Q1 Season With Sales Drop

Merck KGaA Eyes Job Cuts at Drugs Unit

Biosimilars Seen as a $3.7 billion Drug Market by 2015

Andre Hoffmann: Roche Will Not Be For Sale

Genome Study Brings Blood Cancer Into Sharp Focus

Roche's Strong Pipeline Leaves Shareholders Optimistic

Topics • Technology

The Pharmaceutical Industry On The Move

EU Presses Pharma Companies for More Info on Patent Deals

Alan Hippe to Leave ThyssenKrupp, Will Join Roche as CFO in April

Novartis Starts Phase II Trial for Copy of Roche's Rituxan

Novartis to Slash 1,400 U.S. Jobs

Novartis: No Plans to Slash Jobs

Biosimilar Antibodies: EMA Adopts Guideline

Biosimilar Antibodies: EU Likely to Be Cautious

Roche Buys Bioimagene for $100 Million, Boosts Diagnostics

EU Agency Allows Access to Drug Side Effects Data

Sanofi's Best Bet Still May Be Smaller Deals

White Knight Could Be Elusive For Genzyme

Big Pharma Stocks Could Rally in the Next Year

EU Drugs Agency Under Fire Again For Data Secrecy

Roche Maintains Focus as Industry Faces Cutbacks

Teva Tests Biosimilar Version of Roche's Rituxan

4 more articles

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Event Sponsorship: Next Generation Batteries and Hydrogen

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Predictive Simulation in Pharma Production

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Interview

The UK Chemical Supply Chain

Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Thomson Reuters

CHEManager International c/o Wiley-VCH GmbH

LISA Life Science Austria

Novartis Vaccines and Diagnostics GmbH & Co.KG

Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences

GlaxoSmithKline (GSK) plc

Datamonitor Group

Roche Group

Novartis International AG

Arthur D. Little

Lilly Deutschland GmbH

Dishman Europe Ltd.

Styron Europe GmbH

F. Hoffmann-La Roche Ltd

Bayer AG - Pharmaceuticals Communications & Health Policy

SchüllerConsulting